Board Meeting on March 30, 2015
Concord Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 30, 2015, inter alia, to consider and approve the following:1. Appointment of Ms. P. Chandra Kala as Woman Director.2. Appointment of Secretarial Auditor for the financial year 2014-15.3. Redesignation of Mr. Koni Reddy as Director & CFO. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Concord Drugs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
S Jhansi has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Concord Drugs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
M Ramachandra Reddy has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Financial Results for Dec 31, 2014 (Standalone)
Concord Drugs Ltd has informed BSE about the Standalone Financial Results for the period ended December 31, 2014. Listing of equity shares of Concord Drugs Ltd
Trading Members of the Exchange are hereby informed that effective from February 23, 2015, the equity shares of Concord Drugs Ltd (Scrip Code: 538965) are listed and admitted to dealings on the Exchange in the list of 'DT' Group Securities. For further details please refer to the notice no 20150219-13 dated February 19, 2015. Shareholding Pattern For December 31, 2014
Concord Drugs Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.